Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Neuro-Oncology|February 15, 2013
IDH/MGMT-driven molecular classification of low-grade glioma is a strong predictor for long-term survivalSeverina Leu, Stefanie von Felten, Stephan Frank, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Ancient IL-6-STAT5 signaling orchestrates inflammation in jawless vertebratesFrancisco Fontenla-Iglesias, Jean-Louis Boulay, Jonathan P Rast, et al.
Journal of Neuro-Oncology|November 19, 2016
Reverse phase protein arrays enable glioblastoma molecular subtypingGregor Hutter, Martin Sailer, Tej Deepak Azad, et al.
International Journal of Oncology|September 30, 2009
The 10q25.3-26.1 G protein-coupled receptor gene GPR26 is epigenetically silenced in human gliomasJean-Louis Boulay, Mihai-Constantin S Ionescu, Balasubramanian Sivasankaran, et al.
Plos One|June 28, 2007
Loss of NOTCH2 positively predicts survival in subgroups of human glial brain tumorsJean-Louis Boulay, André R Miserez, Christian Zweifel, et al.
Cancer Cell|December 17, 2015
A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor SubtypesClaudio Giachino, Jean-Louis Boulay, Robert Ivanek, et al.
Cancer Research|January 17, 2009
Tenascin-C is a novel RBPJkappa-induced target gene for Notch signaling in gliomasBalasubramanian Sivasankaran, Martin Degen, Anthony Ghaffari, et al.
Brain Pathology (Zurich, Switzerland)|November 8, 2018
Regulation of glioma cell invasion by 3q26 gene products PIK3CA, SOX2 and OPA1Thorsten Schaefer, Archana Ramadoss, Severina Leu, et al.
Nature Communications|November 9, 2024
Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blockerTomás A Martins, Deniz Kaymak, Nazanin Tatari, et al.
Pageof 3